MindBeacon launches new Digital Alcohol Use Management Therapy Program in consultation with experts from the Centre for Addiction and Mental health

Toronto, May 11, 2021 (GLOBE NEWSWIRE) -- MindBeacon Holdings Inc. (TSX: MBCN), leading provider of digital mental and behavioural health therapy, today announced the launch of a new digital therapy targeting alcohol use. Developed in consultation with experts at The Centre for Addiction and Mental Health (CAMH), the new program uses the principles of cognitive behavioural therapy (CBT) and a harm reduction approach to manage alcohol consumption and develop strategies to cope with cravings.

New research on substance use during the pandemic suggests alcohol consumption among Canadians has increased since the onset of the pandemic with nearly a quarter (24 per cent) of Canadians reporting increased alcohol consumption (Statistics Canada). Crafted by a team of psychologists and social workers at MindBeacon in consultation with addiction experts at CAMH, the “Managing Alcohol Use” program is designed to help Canadians build healthy relationships with alcohol. The eight to twelve-week Therapist Guided Program combines leading cognitive behavioural principles to equip Canadians with mild to moderate alcohol usage habits with the skills to manage thoughts, behaviours and physical symptoms associated with drinking by creating strategies to monitor daily intake, identify triggers and set goals.

"The Managing Alcohol Use program is an innovative digitally-delivered therapy to focus on alcohol use and provide evidence-based solutions for Canadians looking to change their relationship with alcohol and lead a healthier life,” says Dr Peter Farvolden PhD, CPsych, Chief Science Officer of MindBeacon. “Canadians are turning to alcohol to manage stress, ease boredom and contend with irregular schedules. Social isolation brought about by the pandemic is also driving alcohol consumption. While in the short term alcohol may feel like a stress reliever, research has found that alcohol consumption actually worsens depression and anxiety.”

“Many Canadians exceed Canada’s current low-risk drinking guidelines, which recommend no more than 10 drinks a week for women, and 15 drinks a week for men. These guidelines are now 10 years old and higher than the suggested limits in countries with more up-to-date guidelines including Ireland, France, Australia, UK and the United States,” says Dr Kevin Shield, Independent Scientist, Institute for Mental Health Policy Research, and Head, World Health Organization/Pan American Health Organization Collaborating Centre at the Centre for Addiction and Mental Health.  “The health benefits of alcohol are currently overstated and the risks underestimated – most alarmingly, for cancer. Low-risk drinking guidelines also assume people are “free” to choose their consumption, which may not entirely be the case as alcohol is an addictive substance. It would be similar to having low-risk smoking guidelines, which would not make sense as nicotine is addictive.”

To launch the Managing Alcohol Use program, MindBeacon will host a free “Ask a Therapist” webinar on May 19, 2021. Dr. Kevin Shield will be sharing eye-opening new data on alcohol use in Canada and some powerful information about both its physical and mental health affects on Canadians. Dr. Leorra Newman C.Psych, MindBeacon Clinical Content Lead, and Jennifer Baldachin MSW., BSW, MindBeacon therapists will also be answering pressing questions around seeking help for better managing alcohol use and the new therapy program. You can register for the free webinar here.

The Managing Alcohol Use therapy program is available to all Canadian adults seeking mental health support through MindBeacon, whether through MindBeacon’s Workplace Mental Health Program or as a reimbursable benefit through most major Canadian group health benefit plans.

About MindBeacon

MindBeacon provides a continuum of mental healthcare that includes self-guided psychoeducational and wellness content, Peer-to-Peer Support, Direct Messaging Therapy, Therapist Guided Programs and Live Therapy Sessions all offered virtually through their secure and private platform. As one of the first commercially available, digitally-native platforms to offer therapist-assisted internet-based Cognitive Behavioural Therapy in Canada, MindBeacon’s professional service is designed around end users – their health, their way. Working with employers, insurance carriers and government ministries, MindBeacon’s services are accessible, available, affordable and, most importantly, proven to be effective. MindBeacon is changing the therapy landscape by making professional care available to every Canadian, no matter when, where and how they choose to access it.

About The Centre for Addiction and Mental Health (CAMH)

CAMH is Canada's largest mental health and addiction teaching hospital and a world leading research centre in this field. CAMH combines clinical care, research, education, policy development and health promotion to help transform the lives of people affected by mental illness and addiction. CAMH is fully affiliated with the University of Toronto and is a Pan American Health Organization/World Health Organization Collaborating Centre. For more information, please follow @CAMHnews on Twitter.

For further information:

(e): media@mindbeacon.com

SOURCE MindBeacon Holdings Inc.

HAEGARDA® is now available in all of Canada for the routine prevention of Hereditary Angioedema (HAE) attacks in adolescent and adult patients

OTTAWA, ON, May 11, 2021 /CNW/ - CSL Behring Canada announced that HAEGARDA® (C1 Esterase Inhibitor Subcutaneous [Human]), is now available in all of Canada. HAEGARDA is a subcutaneous C1 esterase inhibitor (C1-INH) therapy indicated for routine prevention of Hereditary Angioedema (HAE) attacks in adolescent and adult patients.1  HAE patients have absent or low levels of endogenous or functional C1-INH.1 Administration of HAEGARDA replaces the missing or malfunctioning C1-INH protein in patients with HAE.The efficacy and safety of HAEGARDA for routine prophylaxis to prevent HAE attacks were demonstrated in a multicenter, randomized, double-blind, placebo-controlled, crossover study which showed that the median percentage reduction in the number of HAE attacks relative to placebo was 95.1% on 60 IU/kg HAEGARDA.1,2

"Hereditary Angioedema (HAE) is a rare disease that results in unpredictable, painful swelling of various body parts which may be potentially life threatening. As a physician that treats this disease, I'm pleased to have HAEGARDA available for patients across Canada. HAEGARDA represents another needed therapeutic  advancement for the prevention of HAE as the only Subcutaneous C1 Inhibitor for preventative therapy approved in Canada," said Dr. Stephen D Betschel, Clinical Immunologist and Allergist, St. Michael's Hospital, Toronto.

HAE is caused by deficient or dysfunctional C1-INH, a protein in the blood that helps to control inflammation, and causes the edema attacks associated with the disease. Depending on the severity of the disease, patients could experience several debilitating attacks each month. Laryngeal attacks, which are experienced by more than half of all HAE patients during their lifetime block the airway and can be fatal – with mortality rates as high as 33 percent in untreated patients3,4,5

HAE Canada commented on the HAEGARDA availability in this statement: "HAE Canada President, Jacquie Badiou, COO, Daphne Dumbrille, and the Board of Directors, are excited that at long last, HAEGARDA is now equally available, without restrictions, to adolescent and adult HAE patients across Canada. This represents yet another milestone for the advancement of care for Canadian HAE patients who need a subcutaneous C1 esterase inhibitor therapy."

CSL Behring Canada also assists patients to get access to training for the administration of HAEGARDA® via the CSL Behring PLUS+ program that offers services and educational materials. Patients can ask their Healthcare professionals to enroll them in the program at any time. 

For more information and a complete risk/benefit profile, please contact Customer Service at 1-866-773-7721 ext. 2386 or refer to the Product Monograph available on CSL Behring website at https://www.cslbehring.ca/products/product-list

About Hereditary Angioedema 

HAE is a rare genetic disorder caused by a deficient or dysfunctional C1-INH protein. It is inherited in an autosomal dominant manner. Symptoms of HAE include episodes of edema, or swelling, in the hands, the feet, the face, the abdomen, and/or the larynx. Patients who have abdominal attacks of HAE can experience episodes of extreme pain, diarrhea, nausea and vomiting caused by swelling of the intestinal wall. HAE attacks that involve the face or throat can result in upper airway closure, asphyxiation and, if untreated, death. Diagnosis of HAE requires a blood test to confirm low or abnormal levels of C1-INH.

About CSL Behring

CSL Behring is a global biotherapeutics leader driven by its promise to save lives. Focused on serving patients' needs by using the latest technologies, we develop and deliver innovative therapies that are used to treat coagulation disorders, primary immune deficiencies, hereditary angioedema, respiratory disease, and neurological disorders. The company's products are also used in cardiac surgery, organ transplantation, burn treatment and to prevent hemolytic disease of the newborn.

CSL Behring operates one of the world's largest plasma collection networks, CSL Plasma. The parent company, CSL Limited (ASX:CSL), headquartered in Melbourne, Australia, employs more than 27,000 people, and delivers its life-saving therapies to people in more than 100 countries. For more information visit www.cslbehring.com and follow us on www.Twitter.com/CSLBehring.

1.HAEGARDA® Product Monograph. CSL Behring Canada, Inc. August 13, 2019
2.Longhurst H, Cicardi M, Craig T, et al. Prevention of Hereditary Angioedema Attacks with a Subcutaneous C1 Inhibitor. N Engl J Med. 2017;376(12):1131-1140. 
3.Bork K, et al. Clinical studies of sudden upper airway obstruction in patients with hereditary angioedema due to C1 esterase inhibitor deficiency. Ach Intern Med. 2003;163:1229-35.
4.Bork K, et al. Efficacy of different medical therapies for the treatment of acute laryngeal attacks of hereditary angioedema due to C1-esterase inhibitor deficiency. J Emerg Med. 2016;50(4):567-80.
5.Bork K, et al. Fatal laryngeal attacks and mortality in hereditary angioedema due to C1-INH deficiency. J Allergy Clin Immunol. 2012 Sep;130(3):692-7

SOURCE CSL Behring

Secrets Threaten to Unravel Family Ties in The Wool Over Their Eyes

Dallas, TX, May 10, 2021 — At 18, Natalia Foster knew seven things about the biological father she’d never met: he was tall, dark, handsome and Italian. He was also married to someone other than Natalia’s mother, had three children and, clearly, no morals. Now, at age 28, Natalia knows something new: her father is dying.

The Wool Over Their Eyes, from Dione Martin, is an authentic, heartfelt story about complex family dynamics and the emotions that must be unpacked when long-buried secrets push their way to the surface.

Illegitimate and bi-racial, Natalia is the secret that her father, Joe, planned to take to his grave. His wife and family know nothing of Natalia’s existence — or that her mother is Black — but when word spreads that Joe has only months to live, Natalia feels compelled to meet him and salvage what little time with him she has left. But at what cost to Joe’s devoted wife, Rosa, and their grown children?

In the midst of Natalia’s family drama and pain is also a love story. Natalia must choose between two loves — a long-lost one and a new one. Her ex-boyfriend, Tyler Davis, who captured her heart and connected with her soul, resurfaces. But she meets a handsome doctor, David Duplessis, who’d cared for her father. Just as the relationship begins to blossom, David commits an act that severs her trust and sends her spiraling further into her dark abyss. 

The Wool Over Their Eyes is loosely based on Martin’s personal experiences. She drew upon her own memories and insights of growing up without her biological father and being betrayed in her own marriage to inform her narrative and give her characters depth and authenticity.

“I wrote The Wool Over Their Eyes for fatherless girls, for women who have been betrayed, for those who have been rejected because of their race (or otherness) and for families that have been torn apart by secrets, lies and deception,” Martin reflects. “Healing is possible – through change, through empathy, through faith and through forgiveness.” 

Author Dione Martin was born and raised in New Orleans, where she spent much of her childhood and teen years reading. She earned her Bachelor’s in English from the University of Minnesota-Morris and her Master’s in Journalism from the University of Texas at Austin. She is currently a senior communications director at Brinker International. She lives in Dallas with her two daughters and enjoys running, cooking, performing arts and attempting DIY projects. The Wool Over Their Eyes is her debut novel, and she is working on her next one.

​For more information about the author, please visit www.dione-martin.com or follow her on Twitter (@DioneMartin30), LinkedIn (www.linkedin.com/in/dione-martin/) or Facebook (www.facebook.com/dionehmartin).

The Wool Over Their Eyes

Publisher: Inspire on Purpose

ISBN-10: 1948903539 

ISBN-13: 978-1948903530 

Available from Amazon.com

###

Expert Speaker, Renowned Psychiatrist Provides Healthy Path Forward Amid World Unrest 

Chattanooga, TN, May 10, 2021 ― It seems that every day the news gets worse. Mass killings. Officer-involved shootings. Social upheaval. The pandemic. And everyone just trying their best to adjust to a new normal amid swirling unrest. It’s a lot for the brain to process. Do we react with fear? Anxiety? Anger? Or can we teach our brains to push pause and unpack the facts first, instead of allowing the seemingly endless stream of negative news to impact our mental, emotional and spiritual health?

Timothy R. Jennings, M.D., is a board-certified psychiatrist, master psychopharmacologist and highly sought-after speaker who regularly addresses the topic of brain health to both non-medical and medical audiences. His subjects include Major Depression in the Primary Care Setting and the Neurobiology of Depression, Alzheimer’s Dementia, Psychotherapy in Clinical Practice, Spirituality in Medicine, Depression and its Spiritual and Physical Connections — among many others.
 

A common thread among his discussion topics is how anxiety-inducing news and events can activate the brain’s stress pathways — thereby increasing the body’s inflammatory factors, diminishing immune response and increasing vulnerability to viral infections and cancer. The good news is, we can rewire the way our brains react to negative news and stressful events, and Dr. Jennings can explain how. 

As a Christian psychiatrist, Dr. Jennings also speaks to design principles that, when embraced and followed, can lead to a better understanding of the world and bring about more peace. 

As the world searches for a clear path toward physical and mental recovery, Dr. Jennings is uniquely poised to address the very serious subject of brain health from both scientific and spiritual perspectives — a much needed and welcomed approach during these extremely distressing times.

Dr. Jennings operates a private practice in Chattanooga and has successfully treated thousands of patients. He is a Distinguished Fellow of the American Psychiatric Association and Life-Fellow of the Southern Psychiatric Association. 

###

Blue Hive Health, Canada's First Digital Wellness Clinic Opens Expanding Canadians Access to Personalized Mind-Body Healing

As Canadians suffer from a mental health crisis, Blue Hive Health is on a mission to increase Canadians' access to holistic solutions and improve overall wellbeing.

TORONTO, May 10 2021 /CNW/ - Toronto based Blue Hive Health is Canada's first digital holistic mind-body centre expanding Canadian's access to natural health practices. Using a collaborative educational approach, Blue Hive Health's health and wellness treatments focus on the body, mind and spirit to provide contemporary practices which address multiple aspects of people's wellbeing.

Canadians who report symptoms of mental illness also report experiencing three times as many chronic physical conditions compared to the general population. The correlation between mental and physical health is more pressing now than ever as 1 in every 4 Canadians is dealing with heightened mental health issues due to COVID-19 and its associated lockdowns. With a lack of physical access to health support options Blue Hive Health addresses the gap in the market providing Canadians with an accessible space that serves both mental and physical wellbeing at a time when it is more needed than ever. 

With a framework focused on creating a program that is accessible, educational and most importantly, client focused, Blue Hive Health redefines what virtual wellness services can offer and challenges the way health issues are addressed. Rooted in the principle that people's optimal physical health is dependent on positive mental health, Blue Hive's holistic, mind and body approach firmly believes the only way to truly feel true wellbeing is to find and address the root cause of the problem. 

"For many health issues, the conventional health care system often focuses on treating the symptoms, rather than targeting and addressing the source of the problem," says Stephanie Abouatallah, Co-founder and CEO, Blue Hive Health. "This approach is needed for some health issues, but falls short for others. We founded Blue Hive Health to increase awareness of the benefits of a holistic, mind and body approach to healing, the range of health issues it can alleviate and how it can enhance conventional treatments."

Blue Hive Health's services include Psychotherapy, Holistic Nutrition, Energetic Therapies, Emotional Freedom techniques, Homeopathy, Naturopathy, Functional Medicine, Mindfulness Meditation and Coaching led by expert practitioners. To provide patients with a full mind-body approach, Blue Hive Health offers one-of-kind Journeys; a curated personalized program designed to help guide a person through the maze of holistic wellness and give them a chance to try different approaches and treatments. 

Working with a personal team of practitioners, clients will be introduced to complementary ways to approach their own health journey in a completely custom way. The Journeys include but are not limited to, Stress & Anxiety Relief, Digestive Health Journey, Hormone Rebalancing Journey, Body Positive Journey, Intuitive Eating Journey, Total Body Wellness Journey, as well as custom and corporate programs.

"Blue Hive's Journeys offer a full-mind body approach to healing and introduces a collaborative practice to holistic treatment, designed to support a patient's overall wellbeing," says Giovanna Capozza, Co-Founder and COO, Blue Hive Health.  "For many health issues, a remedy often doesn't come from a single treatment. At Blue Hive, patients are able to receive one-on-one time with a team of practitioners, like a Holistic Nutritionist, Personal Coach and Psychotherapist, at significantly reduced rates, who work together on personalized treatment programs."

As COVID-19 continues to sharpen Canadians' focus on their physical health and mental wellbeing, Blue Hive Health is committed to expanding Canadian's understanding of mind-body holistic treatments and demonstrating their positive impact. Through its diverse services which can be tailored to fit in individual needs, Blue Hive Health is on a mission to increase Canadians' access to holistic treatments and support their overall well being,

SOURCE Blue Hive Health

20 Tenets to Help Women Lead Purposeful, Successful Lives Revealed in The Woman Code

Morning Joe Host & Author of Know Your Value, Mika Brzezinski, Pens Foreword 

Washington, D.C., May 10, 2021 — The pandemic forced everyone to pivot and re-prioritize, and for many women, that meant putting themselves last. Now, more than ever, women need to know their value, recognize their worth and fill their own cups first. 

“Women are the soul of what keeps the world going. We keep our families, our companies, our communities and our nations intact,” explains Sophia A. Nelson, acclaimed journalist and author of The Woman Code: 20 Powerful Keys to Unlock Your Life (April 2021, Health Communications).    

Named one of the most inspirational books by Woman’s Day in 2015-2017, this transformative book is updated with new insights about the profound economic and societal shifts that have changed our world since the pandemic. Nelson guides women through living out a powerful life Code that will lead them to purposeful, meaningful and authentically successful lives. 

Every woman lives by a Code, whether she realizes it or not. It informs how she treats herself and others and how far she is willing to go in order to find success. Nelson calls on women to examine whether the Code they’re living by is truly helping them create the lives they desire. A senior columnist for USA Today and a frequent commentator on CNN, Nelson reveals 20 powerful Codes including:

  • Know Your Value 
  • Be Resilient 
  • Choose Your Thoughts and Words Wisely
  • Lift Other Women as You Climb
  • Practice Love, Laughter, Loyalty

With life quotes from philosophers and poets, mystics and her maternal grandmother, plus her experience as a Black woman rising through the ranks of a male-dominated news industry, The Woman Code is an essential tool of transformation for women to enjoy in reading groups, retreats and Bible study groups. It will help women honor themselves while navigating the demands of work, home, family and friendship no matter what their age or stage in life.

About the Author

Sophia A. Nelson is an award-winning American author and journalist who appears regularly on CNN’s Inside Politics and Newsroom as a legal and political analyst. She is an adjunct professor in the Department of Philosophy and Religion at Christopher Newport University in Newport News, Virginia. 

Nelson covered former First Lady Michelle Obama at the White House from 2010–2012. The author appears frequently on CNN and has been a contributor to MSNBC, NBC, Fox News, the BBC, ABC World News with Diane Sawyer and the Today show. She writes for The Huffington Post Healthy Living and The Daily Beast. She has also contributed to USA Today, Essence, The Wall Street Journal, The New York Times and The Washington Post. She is the author of The Woman CodeBlack Woman Redefined, and E Pluribus ONE.

For more information, please visit https://thewomancodepaperback.com/

The Woman Code: 20 Powerful Keys to Unlock Your Life

Publisher: Health Communications, Inc.

ISBN-13: 978-0757323980  

Available from Amazon.com

Should a Person with Autism Be Allowed to Become a Professional Boxer and Put His Life at Risk?

Forest, VA, May 10, 2021 ― It’s a struggle that parents of children with special needs face every day and well into that child’s adulthood: how much decision-making latitude is safe? 

NOKI is an empowering story from Douglas Farrago, MD, about a young man with autism who wants to become a professional boxer. Life’s circumstances have dictated the reason for him choosing this path. The lawless world of boxing has its reasons for embracing Noki and his abilities. And they are not good ones. So, the debate wages on: Should Noki be allowed to make the life-altering decision to enter the ring and put his life on the line?

Meanwhile, what few know is that Noki is actually a savant and can imitate and transform himself into any legendary boxer he wants — a plot twist that allows NOKI to pay homage to some of the greatest boxers of all time.

Dr. Farrago draws upon his experiences as an All-American collegiate boxer, a sports medicine trainer for professional boxers in Houston and his decades-long career in medicine during which he worked with autism patients to lend authenticity to his characters and narrative.

“Noki becomes somewhat of a hero to those with special needs in this story, which I think is pretty cool,” he said. “I felt it would be nice if a story showed that those with autism don’t need to be anything but themselves, and maybe it is the rest of us who need to change.”

Ultimately, NOKI is a heartwarming story that will spark real conversations about the limits that society places on people with special needs. Knowingly or not. 

Author Douglas Farrago, MD, is board certified in the specialty of Family Practice. Recently retired, he had a large following of autistic and special needs patients in his career. Dr. Farrago is the inventor of the Knee Saver, which is currently in the Baseball Hall of Fame. The Knee Saver and its knock-offs are worn by many major league baseball catchers. He also invented the CryoHelmet, used by athletes for head injuries as well as migraine sufferers. 

Dr. Farrago received his Bachelor of Science from the University of Virginia in 1987, his Master of Education degree in Exercise Science from the University of Houston in 1990 and his Medical Degree from the University of Texas at Houston in 1994. His residency training occurred way up north at the Eastern Maine Medical Center in Bangor. Dr. Farrago still blogs every day on his website Authenticmedicine.com and lectures worldwide about the present crisis in our healthcare system and the effect it has on the doctor-patient relationship. Dr. Farrago has written six books to date, his latest one being NOKI

For more information about NOKI and the author, please visit http://letnokibox.com/

Ogena Solutions launches ozone-free air purifier proven to kill over 99% of airborne viruses

With safety established by CARB-approval and UL2998 certification, the ozone-free air purifier attacks respiratory droplets and exposed surfaces missed by hand cleaning or HEPA filters

STONEY CREEK, Ontario, May 10, 2021 (GLOBE NEWSWIRE) -- Ogena Solutions, a long-time trusted veteran in leading biosecurity practices, is excited to launch the OgenaShield Air Purifier by Puraclenz. Applying an advanced and patented version of the same technology used to clean air in the International Space Station, the OgenaShield Air Purifier by Puraclenz is one of the most technologically advanced, affordable air purifiers on the market.

“The Covid-19 pandemic has underscored the need for effective air purifying solutions, especially in workplaces and where people congregate. This newly advanced and completely ozone-free system combines UV light with a patented catalyst cell to effectively and efficiently break down and destroy viruses in the air and on exposed surfaces,” says Ogena Solutions President and Founder Dave Hachey.

Third-party tests show that the OgenaShield Air Purifier by Puraclenz kills over 99% of the MS2 Bacteriophage (MS2) virus, an accepted surrogate of SARS-CoV-2, the virus that causes the coronavirus disease COVID-19. The MS2 virus qualified as a surrogate virus since it is a type of virus that is far more difficult to kill than the SARS-CoV-2 virus as well as influenza, norovirus, and the common cold.

The California Air Resource Board (CARB) has approved the OgenaShield Air Purifier by Puraclenz as safe for use in the presence of people and animals. CARB is widely accepted as the world’s gold standard for measuring indoor air quality. The air purifiers also have a UL2998 certification for being completely ozone free.

“We take safety very, very seriously. Since day one of our business, our mission at Ogena Solutions has always been to safeguard animals, people and the environment from pathogens and infectious diseases. We don’t allow any products to enter the market until they’ve been thoroughly tested,” says Hachey.

The air purifier is a partnership with the innovative changemakers at Puraclenz. The newly patented technology behind their air purifiers leverages the power of an advanced form of photocatalytic oxidation (PCO). Unlike most air purifiers, the design does not require viruses to pass through the unit but instead the units increase the number of (already present) positive and negative ions in the air where they deactivate and kill pathogens.

In addition, most air purifiers on the market offer no surface deactivation. The OgenaShield Air Purifier by Puraclenz units kill over 60% of viruses on exposed surfaces – a huge game changer for critical sanitization protocols across all types of businesses.

Ogena Solutions offers three air purifier units with coverage ranging from 500 sq. ft. to 3,000 sq. ft. All are commercial grade and ideal for use in businesses such as gyms, doctor/dental offices, lunchrooms, cafeterias, restaurants, schools, senior housing, manufacturing offices and even agriculture worker housing — basically any type of business establishment.

Our compact and easy-to-install units plug into standard wall outlets and come complete with a wall and ceiling mounting bracket. Some of the key features and benefits of the air purifiers include:

  • Purifies air and surfaces continuously 24/7.
  • Eliminates dangerous pathogens.
  • Single unit coverage of up to 3,000 sq. ft. (30,000 cubic feet) and over multiple rooms, dramatically reducing the number of units needed for full coverage.
  • Approved as safe for use in the presence of people and animals by the California Air Resource Board. CARB is widely accepted as the world's gold standard for measuring indoor air quality.
  • UL2998 certification for being completely ozone free.
  • Long lasting, easy to change UV lamp provides 2.5 years of continuous protection.
  • Elegant and compact design
  • Very low operating cost

The units start at $299 USD ($399 CAD), making this product one of the most affordable air purifiers on the market. For more information, visit www.ogenasolutions.com.

About Ogena Solutions
Over the past 16-plus years, Ogena Solutions has forged an identity as one of the most respected animal health biosecurity companies in North America and has been expanding its knowledge and experience into the human health sector. Following a ‘One Health’ philosophy, Ogena Solutions offers innovative, state-of-the-art products and technologies that meet the highest standards for efficacy, efficiency, and safety, providing best-in-class solutions for government agencies, corporations, and small businesses throughout the continent.

Media Cont

Famous Feline Shares Heartwarming Journey from Shelter Kitty to Social Media Sensation

Chicago, IL, May 10, 2021 — From spa days and birthday parties, to playing dress-up and Target “shopping,” the humanlike antics of an affable ginger tabby named Carrot have been shared with the famous feline’s nearly 300K Instagram followers, capturing the attention of human celebs like Ellen DeGeneres and Katie Couric. 

The social media sensation is now giving readers a glimpse into a year in her furry, fun-filled life in her new book, Diary of the Cat Named Carrot, an uplifting, instantly stress-reducing story told from Carrot’s perspective.

From her humble beginnings as a tiny orange stray to being welcomed into a loving family—including Erin Merryn and her young girls Abby, Hannah and baby Claire—through her rise to internet stardom, Diary of the Cat Named Carrot chronicles her remarkable journey.

Carrot lived in the same shelter that had once housed the family’s previous internet star, Bailey, whose adventures were featured in Bailey, No Ordinary Cat. Much like Bailey had, Carrot loves spending time with her human family partaking in typically human pastimes: making mischief with her girl gang; joyriding in a pint-sized pink Barbie Jeep; doing arts and crafts; modeling a pink tutu and flowery headband; enjoying a spa day complete with fluffy robe and cucumber eye treatments; and celebrating Christmas, Easter and every holiday in between. It’s no wonder Carrot’s videos have gone viral—garnering attention from Ellen, the Dodo, Good Morning America, Access Hollywood, People and many other media outlets. 
 

Diary of the Cat Named Carrot is packed with color photos that will leave readers purring with delight. The journal of this sweet, adorable kitty with personality to spare shows us that the human-animal bond runs more than fur deep. It is a love that will last a lifetime. 

Erin Merryn is an author, activist, speaker, wife and mom to three girls—Abby, Hannah and Claire—and a fur baby named Carrot. She was named Glamour Magazine Woman of the Year in 2012 and a People magazine Hero Among Us for her tireless work promoting Erin's Law nationwide with a mission to keep our children safe by educating them about personal body safety. She is the author of Bailey, No Ordinary Cat, Stolen Innocence, Living for Today and An Unimaginable Act.

For more information, please visit http://www.erinslaw.org, or connect with her on Twitter at @erinmerryn; on Facebook at The Cat Named Carrot; on Instagram at the_cat_named_carrot; and on YouTube at https://www.youtube.com/channel/UCrHXnwcgGzuGRJqdtlUMk1A.

Diary of the Cat Named Carrot

Publisher: Health Communications, Inc.

Release Date: March 30, 2021

ISBN-10: 0757323901 

ISBN-13: 978-0757323904 

Available wherever books are sold

###

Limestone Announces Update on Ebbtide Acquisition and Concurrent Financing

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR DISSEMINATION IN THE UNITED STATES

COLLINGWOOD, Ontario, May 10, 2021 (GLOBE NEWSWIRE) -- The Limestone® Boat Company ("Limestone" or the "Company") (TSXV: BOAT), a heritage brand recently re-launched with new ownership, ideals and a revamped model line-up, is pleased to announce an update to its previously announced proposed acquisition of Ebbtide Holdings, LLC ("Ebbtide") of White Bluff, Tennessee (the "Acquisition") and the previously announced proposed offering of up to $17.0 million aggregate principal amount of 10% convertible subordinated unsecured debentures of the Company through a non-brokered private placement (the "Offering").

Acquisition of Ebbtide 

In consideration for all of the issued and outstanding securities of Ebbtide, Limestone has agreed to pay the existing Ebbtide members, as part of the consideration for their Member Units, $2.5M USD of common shares of Limestone, at a price of CDN$0.33 per share, resulting in the issuance of 9,302,256 common shares of Limestone to the Ebbtide members, subject to certain lock-up protections.

“We are grateful for the support of the investment community and the Ebbtide stakeholders, in the belief in our vision for Limestone. Our management team and Board of Directors are working hard to position Limestone to become a top boat builder in North America,” said Telfer Hanson, Chairman of Limestone.

Limestone intends to close the Offering on or about May 12, 2021 followed by the closing of the Acquisition on or about May 13, 2021. The change to the time of closing for each of these transactions, from that previously announced, is not expected to negatively impact the operations of the Company. Each of the Offering and the Acquisition remain subject to customary conditions for closing including approval from the TSX Venture Exchange.

About Limestone

Limestone is a North American designer and manufacturer of recreational and commercial powerboats. Limestone is a heritage brand with a 35-year legacy, renowned for its timeless design, big water performance, quality manufacturing and durability. Crafted in a centrally located manufacturing facility in Tennessee, Limestone features an evolved and expanded product line that will appeal to a growing number of boaters coast to coast.

Limestone is a brand focused Company, dedicated to the wellbeing of all stakeholders, including our customers, employees and shareholders. It is with great pride that the Company continues to expand the legacy of Limestone boats and its original designer, Mark Ellis of Connecticut. Scott Hanson, Mark Ellis and the Limestone design team have worked diligently to modernize the Limestone configurations, designs, adding outboard power, while maintaining the original hull design that has made the Limestone brand famous for its’ big water performance. Please visit www.limestoneboats.com to see the new designs.

For more information, contact: 
Investor Relations: Bill Mitoulas
800-720-2395
bill@limestoneboats.com 
Website: limestoneboats.com

Neither the TSXV nor its Regulation Services Provider (as that term is defined in the policies of the TSXV) accepts responsibility for the adequacy or accuracy of this news release.

Cautionary Note Regarding Forward-Looking Statements

Certain statements contained in this press release constitute forward-looking information. These statements relate to future events or future performance. The use of any of the words “anticipate”, “believe”, “could” “should”, “would”, “estimate”, “expect”, “forecast”, “indicate”, “intend”, “likely”, “may”, “plan”, “potential”, “project”, “outlook”, “seek”, “target”, “trend” or “will” and similar expressions and statements relating to matters that are not historical facts are intended to identify forward-looking information and are based on the parties’ current belief or assumptions as to the outcome and timing of such future events. Actual future results may differ materially. In particular, there are no assurances that the transactions will be completed on the terms or timeframe indicated herein or at all. If these transactions are ultimately completed, the Company will be subject to a number of risks relating to integration and go-forward operations, certain of which are more particularly described in the Company's public filings available on SEDAR. The forward-looking information contained in this release is made as of the date hereof and the parties are not obligated to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, except as required by applicable securities laws. Because of the risks, uncertainties and assumptions contained herein, investors should not place undue reliance on forward looking information. The foregoing statements expressly qualify any forward-looking information contained herein.

Many factors could cause actual results, level of activity, performance or achievements or future
events or developments to differ materially from those expressed or implied by the forward-looking statements. All the forward-looking statements made in this press release are qualified by these cautionary statements and other cautionary statements or factors in this press release. There can be no assurance that the actual results or developments will be realized or, even if substantially realized, will have the expected consequences to, or effects on, the Company. Unless required by applicable securities law, the Company does not intend and does not assume any obligation to update these forward-looking statements.

The securities forming part of the Offering have not been, nor will they be, registered under the United States Securities Act of 1933, as amended (the “1933 Act”) and may not be offered or sold in the United States or to, or for the account or benefit of, “U.S. persons” (as defined in Regulation S under the 1933 Act) absent registration or an applicable exemption from the registration requirements. The securities may be offered in the United States to Qualified Institutional Buyers (as defined in Rule 144A under the 1933 Act) pursuant to exemptions from the registration requirements under rule 144A of the 1933 Act and to “accredited investors” as such term is defined in Rule 501(a)(1), (2), (3) or (7) of Regulation D promulgated under the 1933 Act. This news release will not constitute an offer to sell or the solicitation of an offer to buy nor will there be any sale of the securities in any State in which such offer, solicitation or sale would be unlawful.